107 related articles for article (PubMed ID: 22460823)
1. Changes in the melanocortin receptors in the hypothalamus of a rat model of cancer cachexia.
Suzuki M; Narita M; Ashikawa M; Furuta S; Matoba M; Sasaki H; Yanagihara K; Terawaki K; Suzuki T; Uezono Y
Synapse; 2012 Aug; 66(8):747-51. PubMed ID: 22460823
[No Abstract] [Full Text] [Related]
2. Neural melanocortin receptors are differentially expressed and regulated by stress in rat hypothalamic-pituitary-adrenal axis.
Wachira SJ; Hughes-Darden CA; Nicholas HB; Taylor CV; Robinson TJ
Cell Mol Biol (Noisy-le-grand); 2004 Sep; 50(6):703-13. PubMed ID: 15641161
[TBL] [Abstract][Full Text] [Related]
3. New cancer cachexia rat model generated by implantation of a peritoneal dissemination-derived human stomach cancer cell line.
Terawaki K; Sawada Y; Kashiwase Y; Hashimoto H; Yoshimura M; Suzuki M; Miyano K; Sudo Y; Shiraishi S; Higami Y; Yanagihara K; Kase Y; Ueta Y; Uezono Y
Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E373-87. PubMed ID: 24347053
[TBL] [Abstract][Full Text] [Related]
4. High ambient temperature reverses hypothalamic MC4 receptor overexpression in an animal model of anorexia nervosa.
Gutiérrez E; Churruca I; Zárate J; Carrera O; Portillo MP; Cerrato M; Vázquez R; Echevarría E
Psychoneuroendocrinology; 2009 Apr; 34(3):420-9. PubMed ID: 19022583
[TBL] [Abstract][Full Text] [Related]
5. Cachexia: lessons from melanocortin antagonism.
Deboer MD; Marks DL
Trends Endocrinol Metab; 2006 Jul; 17(5):199-204. PubMed ID: 16750633
[TBL] [Abstract][Full Text] [Related]
6. Anorexic action of deoxynivalenol in hypothalamus and intestine.
Tominaga M; Momonaka Y; Yokose C; Tadaishi M; Shimizu M; Yamane T; Oishi Y; Kobayashi-Hattori K
Toxicon; 2016 Aug; 118():54-60. PubMed ID: 27090011
[TBL] [Abstract][Full Text] [Related]
7. The role of the melanocortin-3 receptor in cachexia.
Marks D; Cone RD
Ann N Y Acad Sci; 2003 Jun; 994():258-66. PubMed ID: 12851324
[TBL] [Abstract][Full Text] [Related]
8. Evidence for direct actions of melanocortin peptides on bone metabolism.
Dumont LM; Wu CS; Tatnell MA; Cornish J; Mountjoy KG
Peptides; 2005 Oct; 26(10):1929-35. PubMed ID: 15979763
[TBL] [Abstract][Full Text] [Related]
9. The neuroendocrine circuitry controlled by POMC, MSH, and AGRP.
Biebermann H; Kühnen P; Kleinau G; Krude H
Handb Exp Pharmacol; 2012; (209):47-75. PubMed ID: 22249810
[TBL] [Abstract][Full Text] [Related]
10. Constitutive receptor activity series: endogenous inverse agonists and constitutive receptor activity in the melanocortin system.
Adan RA
Trends Pharmacol Sci; 2006 Apr; 27(4):183-6. PubMed ID: 16500715
[TBL] [Abstract][Full Text] [Related]
11. Melanocortin 4 receptor activation induces brain-derived neurotrophic factor expression in rat astrocytes through cyclic AMP-protein kinase A pathway.
Caruso C; Carniglia L; Durand D; Gonzalez PV; Scimonelli TN; Lasaga M
Mol Cell Endocrinol; 2012 Jan; 348(1):47-54. PubMed ID: 21803120
[TBL] [Abstract][Full Text] [Related]
12. Proopiomelanocortin and melanocortin receptors in the adult rat retino-tectal system and their regulation after optic nerve transection.
Lindqvist N; Näpänkangas U; Lindblom J; Hallböök F
Eur J Pharmacol; 2003 Dec; 482(1-3):85-94. PubMed ID: 14660008
[TBL] [Abstract][Full Text] [Related]
13. Leptin infusion and obesity in mouse cause alterations in the hypothalamic melanocortin system.
Gout J; Sarafian D; Tirard J; Blondet A; Vigier M; Rajas F; Mithieux G; Begeot M; Naville D
Obesity (Silver Spring); 2008 Aug; 16(8):1763-9. PubMed ID: 18551122
[TBL] [Abstract][Full Text] [Related]
14. Age-related changes in brain-derived neurotrophic factor and tyrosine kinase receptor isoforms in the hippocampus and hypothalamus in male rats.
Silhol M; Bonnichon V; Rage F; Tapia-Arancibia L
Neuroscience; 2005; 132(3):613-24. PubMed ID: 15837123
[TBL] [Abstract][Full Text] [Related]
15. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus.
Mounien L; Bizet P; Boutelet I; Gourcerol G; Fournier A; Vaudry H; Jégou S
Neuroscience; 2006 Nov; 143(1):155-63. PubMed ID: 16962718
[TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin-mediated suppression of feeding involves the brainstem melanocortin system.
Fan W; Ellacott KL; Halatchev IG; Takahashi K; Yu P; Cone RD
Nat Neurosci; 2004 Apr; 7(4):335-6. PubMed ID: 15034587
[TBL] [Abstract][Full Text] [Related]
17. Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes.
Mountjoy KG
Biochem J; 2010 May; 428(3):305-24. PubMed ID: 20504281
[TBL] [Abstract][Full Text] [Related]
18. Age-dependent hypothalamic expression of neuropeptides in wild-type and melanocortin-4 receptor-deficient mice.
Arens J; Moar KM; Eiden S; Weide K; Schmidt I; Mercer JG; Simon E; Korf HW
Physiol Genomics; 2003 Dec; 16(1):38-46. PubMed ID: 14559977
[TBL] [Abstract][Full Text] [Related]
19. Peptoid-peptide hybrids as potent novel melanocortin receptor ligands.
Kruijtzer JA; Nijenhuis WA; Wanders N; Gispen WH; Liskamp RM; Adan RA
J Med Chem; 2005 Jun; 48(13):4224-30. PubMed ID: 15974575
[TBL] [Abstract][Full Text] [Related]
20. Metabolic and melanocortin gene expression alterations in male offspring of obese mice.
Gout J; Sarafian D; Mutel E; Vigier M; Rajas F; Mithieux G; Begeot M; Naville D
Mol Cell Endocrinol; 2010 May; 319(1-2):99-108. PubMed ID: 20097259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
